Understanding affinity variation in the CD28/ CTLA-4 pathway and its impact on immune function.
Understanding affinity variation in the CD28/ CTLA-4 pathway and its impact on immune function.
批准号:
2720581
负责人:
金额:
$0.0万
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
CD 28-CTLA-4系统是控制T细胞免疫应答的核心。虽然CD 28是一种活化受体,但CTLA-4反对这种功能,抑制反应。尽管CD 28和CTLA-4具有相反的功能,但它们共有两个配体,即CD 80和CD 86,这两个配体在亲和力和亲合力特性上都不同。这些不同的配体特征如何影响免疫功能尚不清楚。在这个项目中,我们建议探索配体特征的变化如何影响免疫功能。我们将产生和表征不同的配体变体,以研究它们在一系列免疫环境中的影响。抗原呈递细胞(B细胞系)将被工程化以表达不同的配体,并在不同的配体表达水平下比较功能结果。我们预期在体外研究人类T细胞对不同配体组合的反应,测量它们对T细胞活化、扩增、存活、细胞表型、细胞因子产生和分化的影响。实验将在存在和不存在CTLA-4表达的情况下进行。此外,我们将进行研究,以衡量不同的配体是如何控制CTLA-4 transendocytosis和它们如何影响调节性T细胞(Treg)的稳态。该项目将通过配体变体的克隆和表达及其免疫功能的研究,提供分子生物学、免疫学和细胞生物学方面的培训和经验。总的来说,该项目将详细了解CD 28和CTLA-4配体的生物物理特性及其对免疫细胞功能的调节之间的关系。
英文摘要
The CD28-CTLA-4 system is central to the control of T cell immune responses. While CD28 is an activating receptor, CTLA-4 opposes this function, inhibiting responses. Indeed, genetic deficiency in CTLA-4 function results in autoimmunity and antibody blockade is used to stimulate immunity to cancer therapeutically.Despite their opposing functions, CD28 and CTLA-4 share two ligands, CD80 and CD86, which differ in both affinity and avidity characteristics. How these distinct ligand characteristics affect immune function is not understood. In this project we propose to explore how changes in ligand characteristics impact immune function. We will generate and characterize different ligand variants in order to study their impact in a range of immune settings.Antigen presenting cells (B cell lines) will be engineered to express different ligands and functional outcomes will be compared at different levels of ligand expression. We anticipate studying human T cell responses to different ligand combinations in vitro, measuring their effect on T cell activation, expansion, survival, cellular phenotype, cytokine production and differentiation. Experiments will be carried out both in the presence and absence of CTLA-4 expression. In addition, we will perform studies to measure how different ligands are controlled by CTLA-4 transendocytosis and how they affect regulatory T cell (Treg) homeostasis. The project will provide training and experience in molecular biology, immunology and cell biology via the cloning and expressing of ligand variants and the study of their immune function. Overall, the project will generate a detailed understanding of the relationship between the biophysical characteristics CD28 and CTLA-4 ligands and their regulation of immune cell function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
里氏木霉纤维素酶cbh基因表达系统调控蛋白分析
-
批准号:30670056
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2006
-
负责人:董志扬
-
依托单位: